Similarly, there were 10 papers including 469 patients who were treated with PD-1/PD-L1 agents, out of which 362 were included in the final analysis for PD-1/PD-L1-associated hypophysitis (Table 2) [24-33]. The gene discussed is CD274; the disease is hypophysitis.